Sciety

Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro

This article has 8 authors:
1. Nicola Clementi
2. Elena Criscuolo
3. Roberta Antonia Diotti
4. Roberto Ferrarese
5. Matteo Castelli
6. Roberto Burioni
7. Massimo Clementi
8. Nicasio Mancini
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 31, 2020Latest activity Jun 5, 2020
HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV

This article has 17 authors:
1. Aleksandra Milewska
2. Ying Chi
3. Artur Szczepanski
4. Emilia Barreto-Duran
5. Kevin Liu
6. Dan Liu
7. Xiling Guo
8. Yiyue Ge
9. Jingxin Li
10. Lunbiao Cui
11. Marek Ochman
12. Maciej Urlik
13. Sylwia Rodziewicz-Motowidlo
14. Fengcai Zhu
15. Krzysztof Szczubialka
16. Maria Nowakowska
17. Krzysztof Pyrc
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 31, 2020Latest activity Jun 5, 2020
Orthogonal genome-wide screenings in bat cells identify MTHFD1 as a target of broad antiviral therapy

This article has 17 authors:
1. Danielle E Anderson
2. Jin Cui
3. Qian Ye
4. Baoying Huang
5. Wenhong Zu
6. Jing Gong
7. Weiqiang Liu
8. So Young Kim
9. Biao Guo Yan
10. Kristmundur Sigmundsson
11. Xiao Fang Lim
12. Fei Ye
13. Peihua Niu
14. Xuming Zhou
15. Wenjie Tan
16. Lin-Fa Wang
17. Xu Tan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 30, 2020Latest activity Jun 5, 2020
Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Viruses Reveal Mosaic Pattern of Phylogeographical Distribution

This article has 17 authors:
1. Roshan Kumar
2. Helianthous Verma
3. Nirjara Singhvi
4. Utkarsh Sood
5. Vipin Gupta
6. Mona Singh
7. Rashmi Kumari
8. Princy Hira
9. Shekhar Nagar
10. Chandni Talwar
11. Namita Nayyar
12. Shailly Anand
13. Charu Dogra Rawat
14. Mansi Verma
15. Ram Krishan Negi
16. Yogendra Singh
17. Rup Lal
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 30, 2020Latest activity Jun 5, 2020
Site-specific analysis of the SARS-CoV-2 glycan shield

This article has 5 authors:
1. Yasunori Watanabe
2. Joel D. Allen
3. Daniel Wrapp
4. Jason S. McLellan
5. Max Crispin
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 28, 2020Latest activity Jun 5, 2020
Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity

This article has 5 authors:
1. Yuanmei Zhu
2. Danwei Yu
3. Hongxia Yan
4. Huihui Chong
5. Yuxian He
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 28, 2020Latest activity Jun 5, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

This article has 15 authors:
1. Daniel Wrapp
2. Dorien De Vlieger
3. Kizzmekia S. Corbett
4. Gretel M. Torres
5. Wander Van Breedam
6. Kenny Roose
7. Loes van Schie
8. VIB-CMB COVID-19 Response Team
9. Markus Hoffmann
10. Stefan Pöhlmann
11. Barney S. Graham
12. Nico Callewaert
13. Bert Schepens
14. Xavier Saelens
15. Jason S. McLellan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 28, 2020Latest activity Jun 5, 2020
Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses

This article has 15 authors:
1. K. Reddisiva Prasanth
2. Minato Hirano
3. W. Samuel Fagg
4. Eileen T. McAnarney
5. Chao Shan
6. Xuping Xie
7. Adam Hage
8. Colette A. Pietzsch
9. Alexander Bukreyev
10. Ricardo Rajsbaum
11. Pei-Yong Shi
12. Mark T. Bedford
13. Shelton S. Bradrick
14. Vineet Menachery
15. Mariano A. Garcia-Blanco
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 27, 2020Latest activity Jun 5, 2020
Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo

This article has 6 authors:
1. Stuart Weston
2. Christopher M. Coleman
3. Rob Haupt
4. James Logue
5. Krystal Matthews
6. Matthew B. Frieman
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 27, 2020Latest activity Jun 5, 2020
SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems

This article has 8 authors:
1. Daniel Blanco-Melo
2. Benjamin E. Nilsson-Payant
3. Wen-Chun Liu
4. Rasmus Møller
5. Maryline Panis
6. David Sachs
7. Randy A. Albrecht
8. Benjamin R. tenOever
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 24, 2020Latest activity Jun 5, 2020

Previous Page 76 of 252 Next

Microbiology

Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro

HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV

Orthogonal genome-wide screenings in bat cells identify MTHFD1 as a target of broad antiviral therapy

Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Viruses Reveal Mosaic Pattern of Phylogeographical Distribution

Site-specific analysis of the SARS-CoV-2 glycan shield

Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses

Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo

SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems